by Salome | Jun 25, 2024 | Uncategorized
As a common risk factor for women struggling with infertility, Polycystic Ovary Syndrome (PCOS) affects between 8-13% of all women of reproductive age.4 According to the World Health Organisation (WHO), infertility in women was ranked as the 5th highest and most...
by Salome | Jun 25, 2024 | Uncategorized
With so much conflicting information around, and as such a subjective topic, it can be hard to know if the symptoms that you experience when you get your period are totally ‘normal’, or if there’s something a bit more serious going on. But, if you are suffering from...
by Salome | Jun 25, 2024 | Uncategorized
Despite the fact that it is one of the most common hormonal disorders among women of reproductive age (affecting approximately 8-13% of all women),2 many of those living with Polycystic Ovary Syndrome (PCOS) don’t even know that they have it. Getting a PCOS Diagnosis...
by Salome | Jun 25, 2024 | Uncategorized
Extracted from Pharmacy News, Issue 11, 2021 – Published by Med Suite Media
by Salome | Jun 25, 2024 | Uncategorized
The OTC division of Adcock Ingram has assumed responsibility for the distribution and sales of 3Sixty Biopharmaceuticals’ products. Adcock Ingram OTC is contracted to sell and distribute 3Sixty’s women’s reproductive health products, under the brand...
by Salome | Jun 25, 2024 | Uncategorized
March 2022 marks the official commencement of a collaboration between 3Sixty Biopharmaceuticals and Adcock Ingram’s OTC division. As a result of this collaboration, Adcock Ingram OTC will take over the sales and distribution of 3Sixty Biopharmaceuticals’...
